Lincoln International Analyst Initiates Coverage on Compass Therapeutics with a Buy Rating

HC Wainwright & Co. analyst Brandon Folkes initiated coverage on Traws Pharma and Pelthos Therapeutics with a Buy rating and price targets of $8 and $60, respectively. Canaccord Genuity analyst John Newman initiated coverage on Compass Therapeutics with a Buy rating and a price target of $10. CICC analyst Shanshan Shen initiated coverage on Linde plc with an Outperform rating and a price target of $510. LifeSci Capital initiated coverage on Oculis Holding AG with an Outperform rating and a price target of $55.